Source: Virtual Congress 2021 – Occupational rhinitis and asthma



Rating:

Share or cite this content

Citations should be made in the following way:
E. Suarthana (Montréal , Canada), O. Vandenplas (Namur, Belgium), M. Taghiakbari (Montréal, Canada), J. Pralong (Epalinges-Lausanne, Switzerland), P. Saha-Chaudhuri (Burlington, United States of America), G. Moullec (Montréal, Canada), R. Castano (Montréal, Canada), H. Suojalehto (Työterveyslaitos, Finland), J. Walusiak-Skorupa (Lodz, Poland), X. Muñoz (Barcelona, Spain), J. Sastre (Madrid, Spain), P. Henneberger (Morgantown, United States of America), A. Cartier (Montréal, Canada), C. Lemiere (Montréal, Canada). Diagnostic model for occupational asthma induced by high-molecular-weight agents: A tertiary prevention tool. 1908

Member's Comments

No comment yet.

Related content which might interest you: Occupational asthma: classical and novel causes and diagnostic approaches Source: International Congress 2019 – PG13 Traditional and modern clinical approaches for diagnosis and management of occupational airways diseases Year: 2019 Developing a diagnostic and management tool for childhood asthma in primary care Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008 The prevention of occupational asthma Source: Eur Respir J 2003; 22: 853-860 Year: 2003 Feasibility of using an electronic screening tool for occupational asthma in primary care Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies Year: 2015 Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project) Source: Eur Respir J 2002; 20: Suppl. 38, 329s Year: 2002 Specific immunotherapy added to pharmacologic treatment as a tool for working relocation in baker‘s occupational asthma Source: Annual Congress 2009 - High molecular sensitisers and biological dusts Year: 2009 What is the optimal management option for occupational asthma? Source: Eur Respir Rev 2012; 21: 97-104 Year: 2012 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012 Guidelines for the management of work-related asthma Source: Eur Respir J 2012; 39: 529-545 Year: 2012 Effectiveness of different models of maintenance therapy for bronchial asthma (BA) in routine clinical practice Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007 Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score. Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Managing sub-optimal treatment in COPD: development of an assessment tool for primary care Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Exercise induced asthma: a new challenge in the pediatric population Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008 Biomarkers for the management of severe asthma: a survey Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Monitoring asthma in children: clinical tools Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014